Get the Stockscreener App
20.13
2.94%
-0.61
Pre-market:
20.35
0.22
+1.09%
Omeros Corp stock is traded at $20.13, with a volume of 873.19K.
It is down -2.94% in the last 24 hours and up +4.19% over the past month.
Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.
See More
Previous Close:
$20.74
Open:
$20.52
24h Volume:
873.19K
Relative Volume:
0.45
Market Cap:
$1.46B
Revenue:
-
Net Income/Loss:
$84.01M
P/E Ratio:
23.52
EPS:
0.856
Net Cash Flow:
$-101.16M
1W Performance:
+9.11%
1M Performance:
+4.19%
6M Performance:
+97.74%
1Y Performance:
+379.29%
1-Day Range:
$20.11
$20.62
1-Week Range:
$17.68
$21.24
52-Week Range:
$4.055
$21.24
Omeros Corp Stock (OMER) Company Profile
Name
Omeros Corp
Sector
Industry
Phone
206-676-5000
Address
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Compare OMER vs VRTX, REGN, MRNA, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMER
Omeros Corp
|
20.13 | 1.46B | 0 | 84.01M | -101.16M | 0.856 |
VRTX
Vertex Pharmaceuticals Inc
|
522.38 | 132.40B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
796.02 | 81.95B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
194.82 | 77.78B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
962.22 | 60.20B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
199.86 | 42.84B | 742.00K | -1.37B | -1.07B | -7.0731 |
Omeros Corp Stock (OMER) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-10-25 | Initiated | H.C. Wainwright | Buy |
| Dec-23-24 | Initiated | D. Boral Capital | Buy |
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Dec-08-22 | Downgrade | UBS | Buy → Neutral |
| Nov-08-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Jun-08-22 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-08-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-01-21 | Downgrade | Maxim Group | Buy → Hold |
| Oct-01-21 | Downgrade | Wedbush | Neutral → Underperform |
| Sep-27-21 | Initiated | JP Morgan | Neutral |
| Feb-01-21 | Initiated | UBS | Buy |
| Oct-20-20 | Initiated | BofA Securities | Buy |
| Aug-21-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-14-20 | Reiterated | Maxim Group | Buy |
| May-06-19 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-12-18 | Initiated | Seaport Global Securities | Buy |
| Mar-23-18 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-05-18 | Downgrade | Needham | Buy → Hold |
| Nov-08-17 | Initiated | H.C. Wainwright | Buy |
| May-11-17 | Downgrade | Cantor Fitzgerald | Buy → Neutral |
| Mar-17-17 | Reiterated | Maxim Group | Buy |
| Mar-17-17 | Reiterated | Needham | Buy |
| Nov-16-16 | Reiterated | Wedbush | Outperform |
| Nov-10-16 | Reiterated | Needham | Buy |
| Aug-10-16 | Reiterated | Maxim Group | Buy |
| Jun-03-16 | Initiated | Cantor Fitzgerald | Buy |
| Mar-02-16 | Reiterated | Needham | Buy |
| Feb-29-16 | Reiterated | Wedbush | Outperform |
| Nov-11-15 | Reiterated | Needham | Buy |
| Aug-18-15 | Reiterated | WBB Securities | Strong Buy |
| Aug-10-15 | Initiated | ROTH Capital | Buy |
View All
Omeros Corp Stock (OMER) Latest News
Form 4 Omeros Corporation For: 24 September By Investing.com - Investing.com Nigeria
Omeros VP finance David Borges sells $419,000 in shares By Investing.com - Investing.com Canada
AstraZeneca's Rare Disease Setback Is A 'Clear Positive' For Omeros, Says This Analyst – A Look At Some Key Highlights - Stocktwits
Stock options are the source of shares in officer David Borges's proposed Omeros (OMER) sale. - Stock Titan
Omeros Corporation (OMER) Stock Price, News, Quote & History - Yahoo Finance
Omeros (NASDAQ: OMER) officer to sell 10,000 shares via option exercise - Stock Titan
Omeros Corp (OMER) Hits 52-Week High as Cantor Fitzgerald Upgrades on Yartemlea Sales Outlook - GuruFocus
NTRA Stock Hits All-Time High, OMER Stock Scales 5-Year Peak – What’s Driving Investors’ Enthusiasm Today? - Stocktwits
Omeros Shares Rise After Cantor Fitzgerald Upgrade - marketscreener.com
Omeros Transplant Drug Could Be Bigger than Expected, Says Analyst - Benzinga
Omeros Corporation stock hits 52-week high at 19.75 USD By Investing.com - Investing.com Nigeria
Omeros Corporation stock hits 52-week high at 19.75 USD - Investing.com
This Plexus Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
Cantor Fitzgerald upgrades Omeros stock rating on Yartemlea launch - Investing.com
OMER Stock Surges 5% After Hours On Novo Nordisk Deal Windfall And Drug Launch Optimism - Stocktwits
Omeros Stock Price Forecast. Should You Buy OMER? - StockInvest.us
Omeros Corporation (OMER) Slides 4.49% to $18.52, Drifting Toward Key SupportKAMA Signal - careplusvn.com
Omeros Corp VP and General Counsel Peter B. Cancelmo Executes Stock Option Exercises and Sells Shares - Kalkine Media
Omeros Insider Sold Shares Worth $929,668, According to a Recent SEC Filing - marketscreener.com
Omeros VP, finance & CAO David Borges sells $206,804 in shares By Investing.com - Investing.com South Africa
Omeros VP, finance & CAO David Borges sells $206,804 in shares - Investing.com Nigeria
Omeros (NASDAQ: OMER) insider plans second 25,000-share stock sale - Stock Titan
What Makes Omeros (OMER) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Omeros VP of finance David Borges sells $206,804 in shares By Investing.com - Investing.com Nigeria
Omeros VP of finance David Borges sells $206,804 in shares - Investing.com
Omeros Corp (OMER) Director Thomas Cable Sells 15,000 Shares - GuruFocus
Omeros director Thomas Cable sells $276,772 in company stock - Investing.com
Omeros director Thomas Cable sells $276,772 in company stock By Investing.com - Investing.com Canada
Omeros (NASDAQ:OMER) Director Thomas Cable Sells 15,000 Shares - MarketBeat
Omeros (NASDAQ: OMER) officer to sell 10,906 shares - Stock Titan
Omeros Corp (OMER) director lines up fresh stock sale - Stock Titan
Pomerantz investigates Omeros after CHMP negative opinion - scanx.trade
Omeros (NASDAQ:OMER) Sets New 52-Week HighStill a Buy? - MarketBeat
Omeros stock hits 52-week high at 18.16 USD - Investing.com
Omeros stock hits 52-week high at 18.16 USD By Investing.com - Investing.com Canada
Omeros Corp (OMER) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Omeros Corp (HAM:3O8) Stock Price, Trades & News - GuruFocus
Omeros VP, finance & CAO Borges sells $84,750 in shares - Investing.com India
Omeros VP, finance & CAO Borges sells $84,750 in shares By Investing.com - Investing.com South Africa
Omeros (NASDAQ:OMER) CAO David Borges Sells 5,000 Shares of Stock - MarketBeat
HC Wainwright Comments on Omeros' Q3 Earnings (NASDAQ:OMER) - MarketBeat
OMER Stock On Track For Best Week In Nearly 4 Months After Receiving Permanent Reimbursement Code For Treatment - Stocktwits
Teleconferência de Resultados do 2T26 da Omeros (OMER): Vendas do YARTEMLEA Atingem US$ 28,5 Milhões - TradingKey
Wall Street Zen Upgrades Omeros (NASDAQ:OMER) to Buy - MarketBeat
Omeros Corporation (NASDAQ:OMER) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Omeros (OMER) Turns Profitable As Investors Ask If The Repricing Has Gone Too Far - Yahoo Finance
Omeros Corporation Releases Q2 2026 Earnings Call Summary as Pipeline Development Remains in Focus - Vinanet
What is HC Wainwright's Forecast for Omeros FY2029 Earnings? - MarketBeat
Omeros Corporation $OMER Shares Purchased by Dimensional Fund Advisors LP - MarketBeat
OMER SWOT Analysis: Key Insights from the 10-Q Filing - GuruFocus
OMEROS CORP SEC Filing (Aug 13, 2026) - Stock Titan
Omeros Corp Stock (OMER) Financials Data
Revenue
Net Income
Cash Flow
EPS
Omeros Corp Stock (OMER) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Borges David J. | VP, Finance & CAO |
Sep 22 '26 |
Option Exercise |
3.44 |
10,000 |
34,350 |
10,000 |
| Borges David J. | VP, Finance & CAO |
Sep 23 '26 |
Sale |
20.95 |
10,000 |
209,500 |
0 |
| Borges David J. | VP, Finance & CAO |
Sep 22 '26 |
Sale |
20.95 |
10,000 |
209,500 |
0 |
1.11%
1.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):